Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nasdaq  >  Ligand Pharmaceuticals Inc.    LGND

LIGAND PHARMACEUTICALS INC. (LGND)
Mes dernières consult.
Most popular
  Report  
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsofficial PublicationsSector newsTweets

Ligand Pharmaceuticals Inc. : SHAREHOLDER ALERT: The Law Firm of Levi & Korsinsky, LLP Launches an Investigation into Possible Breaches of Fiduciary Duty by the Board of Directors of Ligand Pharmaceuticals Incorporated

share with twitter share with LinkedIn share with facebook
share via e-mail
0
05/17/2013 | 06:55pm CEST

NEW YORK, May 17, 2013 /PRNewswire/ -- Levi & Korsinsky, LLP is investigating Ligand Pharmaceuticals Incorporated (NasdaqGM: LGND), and its Board of Directors, in connection with possible claims of breaches of fiduciary duty.

(Logo: http://photos.prnewswire.com/prnh/20120409/MM84375LOGO)

To get more information, click here: http://zlk.9nl.com/ligand-pharmaceuticals-lgnd/. There is no cost or obligation to you.

If you own common stock in Ligand Pharmaceuticals Incorporated and wish to obtain additional information, please contact Eduard Korsinsky, Esq. either via email at [email protected] or by telephone at (212) 363-7500, toll-free: (877) 363-5972, or visit http://zlk.9nl.com/ligand-pharmaceuticals-lgnd/.

Levi & Korsinsky is a national firm with offices in New York, New Jersey, and Washington D.C. The firm has extensive expertise in prosecuting securities litigation involving financial fraud, representing investors throughout the nation in securities and shareholder lawsuits. The attorneys at Levi & Korsinsky have been appointed by numerous courts throughout the country to serve as lead counsel on behalf of shareholders in major securities lawsuits and have successfully recovered multimillion-dollar damages awards on behalf of investors. For more information, please feel free to contact any of the attorneys listed below. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:
Levi & Korsinsky, LLP
Eduard Korsinsky, Esq.
30 Broad Street - 24th Floor
New York, NY 10004
Tel: (212) 363-7500
Toll Free: (877) 363-5972
Fax: (212) 363-7171
www.zlk.com

SOURCE Levi & Korsinsky, LLP


© PRNewswire 2013
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on LIGAND PHARMACEUTICALS INC
04/24LIGAND PHARMACEUTICALS : to Report First Quarter 2018 Results on May 8th
BU
04/13LIGAND PHARMACEUTICALS INC : Other Events (form 8-K)
AQ
04/12TAKEDA PHARMACEUTICAL : Roivant, Arbutus launch RNA-focused newco Genevant
AQ
04/04LIGAND PHARMACEUTICALS : Enters into Agreement with venBio to Make Worldwide Omn..
AQ
03/31LIGAND PHARMACEUTICALS : Enters into Agreement with venBio to Make Worldwide Omn..
AQ
03/30LIGAND PHARMACEUTICALS : Enters into Agreement with venBio to Make Worldwide Omn..
BU
03/23RETROPHIN, INC. (NASDAQ : RTRX) Files An 8-K Entry into a Material Definitive Ag..
AQ
03/22LIGAND PHARMACEUTICALS INC : Entry into a Material Definitive Agreement (form 8-..
AQ
03/19LIGAND PHARMACEUTICALS INC. : Today’s Research Reports on Trending Tickers: Liga..
AC
03/09LIGAND PHARMACEUTICALS : to Participate in Two Upcoming Investor Conferences
AQ
More news
News from SeekingAlpha
04/24Ligand Pharma, iRhythm Tech new shorts at Lakeland Capital 
04/04Ligand's Market Valuation Does Not Withstand Scrutiny 
03/22Ligand Pharma amends sparsentan sublicense agreement with Retrophin 
03/12EXELIXIS, INC. AND BIOTECH DEVELOPER : An Understanding Today 
03/07YOUR DAILY PHARMA SCOOP : Esperion's Positive Data, Adamis Results, Mesoblast Ge..